Engineering Antibody Fragments and Single-Domain Antibodies for Research and Clinical Use

Antibodies have long been the cornerstone of immunology, diagnostics, and therapeutic development. Their ability to...

Engineering Antibodies with Extended Half-Life for Long-Term Therapeutic Efficacy and Safety

Therapeutic monoclonal antibodies (mAbs) have revolutionized the treatment of a wide range of diseases, including...